Tryptophan metabolism and disposition in cancer biology and immunotherapy.


Journal

Bioscience reports
ISSN: 1573-4935
Titre abrégé: Biosci Rep
Pays: England
ID NLM: 8102797

Informations de publication

Date de publication:
30 11 2022
Historique:
received: 02 08 2022
revised: 21 10 2022
accepted: 26 10 2022
pubmed: 27 10 2022
medline: 15 11 2022
entrez: 26 10 2022
Statut: ppublish

Résumé

Tumours utilise tryptophan (Trp) and its metabolites to promote their growth and evade host defences. They recruit Trp through up-regulation of Trp transporters, and up-regulate key enzymes of Trp degradation and down-regulate others. Thus, Trp 2,3-dioxygenase (TDO2), indoleamine 2,3-dioxygenase 1 (IDO1), IDO2, N'-formylkynurenine formamidase (FAMID) and Kyn aminotransferase 1 (KAT1) are all up-regulated in many cancer types, whereas Kyn monooxygenase (KMO), kynureninase (KYNU), 2-amino-3-carboxymuconic acid-6-semialdehyde decarboxylase (ACMSD) and quinolinate phosphoribosyltransferase (QPRT) are up-regulated in a few, but down-regulated in many, cancers. This results in accumulation of the aryl hydrocarbon receptor (AhR) ligand kynurenic acid and in depriving the host of NAD+ by blocking its synthesis from quinolinic acid. The host loses more NAD+ by up-regulation of the NAD+-consuming poly (ADP-ribose) polymerases (PARPs) and the protein acetylaters SIRTs. The nicotinamide arising from PARP and SIRT activation can be recycled in tumours to NAD+ by the up-regulated key enzymes of the salvage pathway. Up-regulation of the Trp transporters SLC1A5 and SLC7A5 is associated mostly with that of TDO2 = FAMID > KAT1 > IDO2 > IDO1. Tumours down-regulate enzymes of serotonin synthesis, thereby removing competition for Trp from the serotonin pathway. Strategies for combating tumoral immune escape could involve inhibition of Trp transport into tumours, inhibition of TDO and IDOs, inhibition of FAMID, inhibition of KAT and KYNU, inhibition of NMPRT and NMNAT, inhibition of the AhR, IL-4I1, PARPs and SIRTs, and by decreasing plasma free Trp availability to tumours by albumin infusion or antilipolytic agents and inhibition of glucocorticoid induction of TDO by glucocorticoid antagonism.

Identifiants

pubmed: 36286592
pii: 231983
doi: 10.1042/BSR20221682
pmc: PMC9653095
pii:
doi:

Substances chimiques

Tryptophan 8DUH1N11BX
NAD 0U46U6E8UK
Glucocorticoids 0
Serotonin 333DO1RDJY
Indoleamine-Pyrrole 2,3,-Dioxygenase 0
Sirtuins EC 3.5.1.-
SLC1A5 protein, human 0
Minor Histocompatibility Antigens 0
Amino Acid Transport System ASC 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2022 The Author(s).

Références

J Am Chem Soc. 2018 Jul 11;140(27):8518-8525
pubmed: 29897749
J Cell Physiol. 2016 Jan;231(1):233-42
pubmed: 26094588
J Neurochem. 1996 Aug;67(2):692-8
pubmed: 8764597
FEBS Lett. 1999 Apr 23;449(2-3):206-10
pubmed: 10338133
Biochemistry. 2010 Jan 19;49(2):393-400
pubmed: 20000589
Molecules. 2017 Dec 05;22(12):
pubmed: 29206151
Int J Tryptophan Res. 2019 Aug 21;12:1178646919868978
pubmed: 31488951
Cell Host Microbe. 2018 Jun 13;23(6):716-724
pubmed: 29902437
Front Oncol. 2018 Dec 12;8:622
pubmed: 30631755
Biochim Biophys Acta. 2010 May;1803(5):527-33
pubmed: 20206212
Clin Cancer Res. 2013 Nov 15;19(22):6163-72
pubmed: 24016618
J Immunother Cancer. 2021 Jul;9(7):
pubmed: 34326168
Nat Commun. 2018 Aug 17;9(1):3294
pubmed: 30120222
Can J Physiol Pharmacol. 1988 Jun;66(6):683-8
pubmed: 3167682
Biochim Biophys Acta. 2015 Feb;1848(2):453-62
pubmed: 25450809
J Biol Chem. 1987 Nov 15;262(32):15422-7
pubmed: 2824460
Front Immunol. 2020 Jun 16;11:1185
pubmed: 32612606
Cell Chem Biol. 2018 Apr 19;25(4):471-482.e7
pubmed: 29478906
Clin Sci (Lond). 2016 Aug 1;130(15):1327-33
pubmed: 27358028
Eur J Cancer Clin Oncol. 1986 Jan;22(1):89-95
pubmed: 3456893
Biosci Rep. 2020 Oct 30;40(10):
pubmed: 33063092
Cancer Lett. 2021 Mar 31;501:234-246
pubmed: 33186654
Gut. 2021 Dec 22;:
pubmed: 34937766
Front Cardiovasc Med. 2017 Jul 20;4:48
pubmed: 28775986
Cell Death Differ. 2002 Oct;9(10):1069-77
pubmed: 12232795
Nat Commun. 2018 May 17;9(1):1981
pubmed: 29773791
J Neurosci Res. 2002 Jun 1;68(5):622-6
pubmed: 12111852
J Neurochem. 1980 May;34(5):1087-92
pubmed: 6154772
Cancers (Basel). 2020 Feb 08;12(2):
pubmed: 32046278
Nutr Diabetes. 2018 May 25;8(1):35
pubmed: 29795366
Ann N Y Acad Sci. 2000;917:376-86
pubmed: 11268363
Proc Natl Acad Sci U S A. 1999 Nov 23;96(24):13978-82
pubmed: 10570184
Int J Cancer. 2011 May 1;128(9):1999-2009
pubmed: 21387284
Front Oncol. 2022 Oct 03;12:977640
pubmed: 36263228
Immunol Cell Biol. 2018 Nov;96(10):1026-1034
pubmed: 29888434
Regen Ther. 2021 Mar 11;17:20-33
pubmed: 33778133
Mol Cancer Ther. 2010 Feb;9(2):489-98
pubmed: 20124451
FEBS Lett. 1987 Jun 15;217(2):221-6
pubmed: 3297781
J Psychopharmacol. 2010 Jun;24(6):809-15
pubmed: 19074538
Microbiome. 2020 May 20;8(1):69
pubmed: 32434586
Biochim Biophys Acta. 2016 Oct;1863(10):2531-9
pubmed: 26724577
Life Sci. 2020 Oct 15;259:118171
pubmed: 32738362
Pharmacol Ther. 2019 Aug;200:27-41
pubmed: 30974124
Int J Tryptophan Res. 2022 Oct 29;15:11786469221122511
pubmed: 36325027
J Neural Transm Gen Sect. 1990;81(3):225-33
pubmed: 2397086
J Biol Chem. 2011 Jun 17;286(24):21767-78
pubmed: 21504897
Cancer Manag Res. 2017 Mar 06;9:65-72
pubmed: 28293120
Cancer Cell. 2018 Mar 12;33(3):480-494.e7
pubmed: 29533786
Biochem J. 2012 Sep 1;446(2):253-60
pubmed: 22690733
Arthritis Res Ther. 2020 Aug 31;22(1):200
pubmed: 32867828
Nature. 2011 Oct 05;478(7368):197-203
pubmed: 21976023
FEBS J. 2021 Oct 22;:
pubmed: 34687129
Nature. 2009 Jul 30;460(7255):587-91
pubmed: 19641587
Prog Neurobiol. 1982;19(1-2):117-39
pubmed: 6131482
Biochem J. 2008 Sep 15;414(3):343-55
pubmed: 18522536
Int J Biol Macromol. 2018 Oct 15;118(Pt A):24-30
pubmed: 29886172
Front Oncol. 2020 Jan 17;9:1514
pubmed: 32010616
Biochem Pharmacol. 2019 Sep;167:149-162
pubmed: 30880062
Crit Rev Oncol Hematol. 2017 Dec;120:203-209
pubmed: 29198333
Eur J Pharmacol. 1993 Oct 1;248(3):237-41
pubmed: 7507440
Integr Med Res. 2014 Dec;3(4):198-203
pubmed: 28664098
Am J Hosp Palliat Care. 2011 Jun;28(4):253-7
pubmed: 21057142
Cancer Immunol Res. 2020 Jan;8(1):19-31
pubmed: 31806639
Eur J Pharmacol. 2021 Apr 5;896:173921
pubmed: 33529725
J Physiol Pharmacol. 2003 Jun;54(2):175-89
pubmed: 12832720
Cell Metab. 2020 Mar 3;31(3):564-579.e7
pubmed: 32130883
J Am Chem Soc. 2012 Feb 15;134(6):3034-41
pubmed: 22299628
Br J Pharmacol. 2016 Dec;173(23):3292-3306
pubmed: 27747870
Front Immunol. 2014 Oct 02;5:458
pubmed: 25324842
Trends Pharmacol Sci. 2021 Jan;42(1):60-73
pubmed: 33256987
Mediators Inflamm. 2018 Feb 18;2018:1601486
pubmed: 29670460
Mol Endocrinol. 2012 Sep;26(9):1542-51
pubmed: 22865928
J Physiol. 2001 Aug 15;535(Pt 1):207-15
pubmed: 11507170
Genes (Basel). 2021 Mar 20;12(3):
pubmed: 33804735
Biosci Rep. 2015 Sep 17;35(5):
pubmed: 26381576
Nat Commun. 2020 Aug 11;11(1):4011
pubmed: 32782249
J Mol Histol. 2013 Aug;44(4):455-61
pubmed: 23547017
J Immunol. 2018 Dec 15;201(12):3683-3693
pubmed: 30429284
World J Gastroenterol. 2020 Dec 7;26(45):7173-7190
pubmed: 33362375
Cell Metab. 2021 Jan 5;33(1):110-127.e5
pubmed: 33171124
Trends Cancer. 2019 Nov;5(11):656-658
pubmed: 31735282
J Psychopharmacol. 2013 Oct;27(10):878-93
pubmed: 23904410
Cancer Res. 2016 Nov 1;76(21):6193-6204
pubmed: 27651314
Exp Gerontol. 2020 Feb;130:110797
pubmed: 31786316
J Biochem. 1985 May;97(5):1371-6
pubmed: 4030727
Cell Host Microbe. 2014 Oct 8;16(4):495-503
pubmed: 25263219
FEBS J. 2008 May;275(9):2078-95
pubmed: 18384385
Mol Aspects Med. 2013 Dec;34(6):1217-56
pubmed: 23370117
Front Pharmacol. 2020 Feb 25;11:110
pubmed: 32158389
Genes Dev. 2020 Mar 1;34(5-6):254-262
pubmed: 32029457
Brain Behav Immun. 2021 Mar;93:245-253
pubmed: 33581247
J Immunol. 2004 Oct 1;173(7):4561-7
pubmed: 15383589
J Biochem. 1982 Oct;92(4):1235-40
pubmed: 7174643
Mol Ther Oncolytics. 2021 Feb 06;20:484-498
pubmed: 33718596
Drug Metab Dispos. 2015 Oct;43(10):1536-43
pubmed: 25873348
Crit Rev Eukaryot Gene Expr. 2014;24(1):15-28
pubmed: 24579667
J Biol Chem. 2020 Dec 25;295(52):17986-17996
pubmed: 33051211
Biol Rev Camb Philos Soc. 2021 Dec;96(6):2522-2545
pubmed: 34137156
J Biol Chem. 2011 Sep 9;286(36):31830-8
pubmed: 21771784
Science. 2017 Aug 25;357(6353):806-810
pubmed: 28775213
Pharmacol Res. 2016 Dec;114:274-283
pubmed: 27816507
J Immunol. 2011 Aug 15;187(4):1617-25
pubmed: 21742973
SLAS Discov. 2018 Apr;23(4):303-320
pubmed: 29557284
J Surg Res. 1996 Feb 1;60(2):389-97
pubmed: 8598675
FASEB J. 2015 Apr;29(4):1395-403
pubmed: 25550456
Exp Gerontol. 2020 Jan;129:110770
pubmed: 31704347
Cancer Res. 2009 Jun 1;69(11):4918-25
pubmed: 19458066
Cancer Res. 2019 Nov 1;79(21):5550-5562
pubmed: 31431462
Cell. 2020 Sep 3;182(5):1252-1270.e34
pubmed: 32818467
Life Sci. 2017 Feb 1;170:72-81
pubmed: 27919824
J Hematol Oncol. 2021 Apr 21;14(1):68
pubmed: 33883013
Egypt J Basic Clin Pharmacol. 2019;9:
pubmed: 31105983
Biochem Pharmacol. 2016 Apr 15;106:94-103
pubmed: 26944194
J Med Chem. 2015 Dec 24;58(24):9421-37
pubmed: 25970480
Toxicol Sci. 2009 Nov;112(1):229-44
pubmed: 19684285
Front Cell Infect Microbiol. 2018 Feb 06;8:13
pubmed: 29468141
Nutrients. 2019 Mar 11;11(3):
pubmed: 30862081
Cancer Res. 1989 Feb 15;49(4):821-5
pubmed: 2643464
Biomed Res Int. 2016;2016:1804137
pubmed: 27218101
Front Immunol. 2021 Apr 13;12:653605
pubmed: 33927722
Biomaterials. 2021 Feb;269:120388
pubmed: 33172606
Toxicol Sci. 2010 May;115(1):89-97
pubmed: 20106948
Int J Mol Sci. 2021 Feb 18;22(4):
pubmed: 33670600
BMC Genomics. 2006 Apr 12;7:80
pubmed: 16611356
Biochem J. 1984 May 15;220(1):341-4
pubmed: 6146313
J Nutr. 1972 Nov;102(11):1547-9
pubmed: 5081686
Mol Aspects Med. 1983;6(2):101-97
pubmed: 6371429
Nat Immunol. 2019 Apr;20(4):420-432
pubmed: 30858618
Mol Cell Biochem. 2017 Jan;425(1-2):59-75
pubmed: 27796684
Front Immunol. 2018 Jan 25;9:53
pubmed: 29422900
Sci Rep. 2015 Aug 03;5:12689
pubmed: 26235394
Mol Cell. 2020 Nov 5;80(3):384-395
pubmed: 32997964
J Clin Endocrinol Metab. 2015 Apr;100(4):1511-9
pubmed: 25636046
ACS Chem Neurosci. 2013 Jan 16;4(1):48-63
pubmed: 23336044
Endocrinology. 1985 Nov;117(5):1788-95
pubmed: 2864234
Nat Rev Drug Discov. 2019 May;18(5):379-401
pubmed: 30760888
Int Immunopharmacol. 2020 Sep;86:106700
pubmed: 32590316
Immunity. 2013 Aug 22;39(2):372-85
pubmed: 23973224
Int J Tryptophan Res. 2017 Mar 15;10:1178646917691938
pubmed: 28469468
Cancer. 1979 Sep;44(3):1003-8
pubmed: 289432
Cell Mol Life Sci. 2020 Apr;77(8):1531-1550
pubmed: 31659416
J Nutr. 1974 Dec;104(12):1584-96
pubmed: 4430932
Biomed Res Int. 2014;2014:196754
pubmed: 24738050
J Biol Chem. 1966 May 10;241(9):2075-83
pubmed: 5946631
Trends Biochem Sci. 2020 Oct;45(10):858-873
pubmed: 32595066
Cell Metab. 2018 May 01;27(5):1067-1080.e5
pubmed: 29685734
Int J Tryptophan Res. 2016 Aug 11;9:51-65
pubmed: 27547037
Expert Opin Ther Targets. 2017 Feb;21(2):167-180
pubmed: 27973928
J Intern Med. 2019 Jul;286(1):32-40
pubmed: 30873652
Adv Exp Med Biol. 1996;398:291-8
pubmed: 8906280
J Exp Med. 2002 Aug 19;196(4):447-57
pubmed: 12186837
J Exp Med. 2011 Mar 14;208(3):519-33
pubmed: 21282379
EBioMedicine. 2020 Apr;54:102717
pubmed: 32268268
Cancer Res. 2003 Jun 15;63(12):3112-20
pubmed: 12810637
J Biol Chem. 2012 Apr 6;287(15):12405-16
pubmed: 22334709
Front Immunol. 2018 Jan 10;8:1957
pubmed: 29379504
Int J Anal Chem. 2014;2014:239641
pubmed: 25548566
Biochem Biophys Res Commun. 2008 Oct 24;375(3):331-5
pubmed: 18694728
Oncotarget. 2014 Feb 28;5(4):1038-51
pubmed: 24657910
Biomed Pharmacother. 2021 May;137:111295
pubmed: 33550042
Naunyn Schmiedebergs Arch Pharmacol. 1978 Jun;303(2):157-64
pubmed: 307698
Front Immunol. 2015 Feb 03;6:34
pubmed: 25691885
Cells. 2019 Aug 09;8(8):
pubmed: 31404966
Endocr Relat Cancer. 2016 Jan;23(1):35-45
pubmed: 26483423
Mol Pharmacol. 2010 Feb;77(2):195-201
pubmed: 19917880
Signal Transduct Target Ther. 2021 Jan 1;6(1):2
pubmed: 33384409
J Leukoc Biol. 2018 Apr;103(4):681-692
pubmed: 29377288
J Cancer Res Clin Oncol. 2010 Nov;136(11):1761-71
pubmed: 20204405
J Leukoc Biol. 2006 Dec;80(6):1320-7
pubmed: 16997853
Int J Tryptophan Res. 2016 Aug 10;9:31-49
pubmed: 27547036
Front Cell Dev Biol. 2020 Nov 19;8:562812
pubmed: 33330446
J Biol Chem. 1965 Mar;240:1395-401
pubmed: 14284754
Biochem Biophys Res Commun. 1986 Jun 30;137(3):1106-11
pubmed: 3488060
Biochem J. 1980 Mar 15;186(3):977-86
pubmed: 7396847
Biochem J. 1985 Jul 15;229(2):499-504
pubmed: 3899109
Cell. 2007 Sep 21;130(6):1095-107
pubmed: 17889652
Pharmacol Res Commun. 1987 Nov;19(11):803-17
pubmed: 2451257

Auteurs

Abdulla A-B Badawy (AA)

Formerly School of Health Sciences, Cardiff Metropolitan University, Western Avenue, Cardiff CF5 2YB, Wales, U.K.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH